AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE698.503.05 (+0.44 %)
PREV CLOSE ( ) 695.45
OPEN PRICE ( ) 696.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 698.50 (1)
VOLUME 97759
TODAY'S LOW / HIGH ( )695.90 704.40
52 WK LOW / HIGH ( )504 895
NSE698.652.95 (+0.42 %)
PREV CLOSE( ) 695.70
OPEN PRICE ( ) 697.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 698.65 (811)
VOLUME 1618248
TODAY'S LOW / HIGH( ) 695.10 704.85
52 WK LOW / HIGH ( )503.05 895
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
21Aug Aurobindo receives nod for Dolutegravi
Aurobindo Pharma has received tentative approval from the US Food &..
21Aug Aurobindo Pharma planning to broaden p
Aurobindo Pharma is planning to broaden portfolio in the US through acce..
21Aug Aurobindo gains on receiving nod for D
Aurobindo Pharma is currently trading at Rs. 706.70, up by 2.20 points o..
11Aug Aurobindo Pharma trades with traction
Aurobindo Pharma is currently trading at Rs. 697.75, up by 14.75 points..
10Aug NHPC, Tata Chemicals and Aurobindo Pha
NHPC has signed the Power Purchase Agreement (PPA) in respect of seven p..
Financials
Rs. in Millions
QTR Jun 17 ANNUAL 17
Net Profit3073.317067.6
Gross Profit 4066.2 21785.7
Operating Profit 5002.625099
Net Sales 21882.997812.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Pfizer (BSE)
 1808.95 (3.16%)
M.Cap (Rs. in Cr)8275.54
Piramal Enterprises (BSE)
 2625.45 (1.81%)
M.Cap (Rs. in Cr)45305.58
Alkem Laboratories (BSE)
 1798.25 (2.66%)
M.Cap (Rs. in Cr)21500.78
Dr. Reddys Lab (BSE)
 2029.50 (2.25%)
M.Cap (Rs. in Cr)33660.66
Ajanta Pharma (BSE)
 1191.25 (3.52%)
M.Cap (Rs. in Cr)10483.71
Shareholding Pattern
PROMOTERS 51.87%
NON-INSTITUTION 14.32%
MUTUAL FUNDS/UTI 13.62%
FI/BANKS/INSURANCE 0.55%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYC
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.